1 [3 (2,4 dichlorophenyl) 5 (furan 2 yl) 4,5 dihydro(1h)pyrazol 1 yl]ethanone [1] |
1 [3 (2,4 dichlorophenyl) 5 (thiophen 2 yl) 4,5 dihydro(1h)pyrazol 1 yl]ethanone [1] |
1 [3 (4 bromophenyl) 5 (furan 2 yl) 4,5 dihydro(1h)pyrazol 1 yl]ethanone [1] |
1 [3 (4 bromophenyl) 5 (thiophen 2 yl) 4,5 dihydro(1h)pyrazol 1 yl]ethanone [1] |
1 [3 (4 chlorophenyl) 5 (furan 2 yl) 4,5 dihydro(1h)pyrazol 1 yl]ethanone [1] |
1 [3 (4 chlorophenyl) 5 (thiophen 2 yl) 4,5 dihydro(1h)py [1] |
1 acetyl 3,5 diaryl 4,5 dihydro(1h)pyrazole derivative [1] |
1,3-oxazine [1] |
14?-demethylase [2] |
16S and ITS rRNA [1] |
2-Arylidenebenzo[b]thiophen-3(2H)-ones [1] |
25 hydroxyvitamin D [1] |
3-Nitropropionic acid [1] |
3-nitropropionic acid [1] |
3-Nitropropionic acid (3-NPA) [1] |
3-NPA- 3-Nitropropionic acid [1] |
3D Culture [1] |
4 [1 (3 fluorobenzyl) 5 indazolylamino] 5 methylpyrrolo[2,1 f][1,2,4]triazine 6 carbamic acid 3 morpholinomethyl ester [1] |
4 Aminobutyric Acid A Receptor [1] |
4 Aminobutyric Acid A Receptor Alpha6 [1] |
5 (2 chlorobenzylideneamino) 1 benzyl 6,7 dihydro 6 (2 chlorophenyl) 1h pyrazolo[3,4 d]pyrimidin 4 (5h)one [1] |
5 (3 methoxy 4 hydroxybenzylideneamino) 1 benzyl 1h pyrazolo[3,4 d]pyrimidin 4 (5h)one [1] |
5 (4 methoxybenzylideneamino) 1 benzyl 6,7 dihydro 6 (4 methoxyphenyl) 1h pyrazolo[3,4 d]pyrimidin 4 (5h)one [1] |
6 [4 (4 ethyl 1 piperazinylmethyl)phenyl] 4 (alpha methylbenzylamino) 7h pyrrolo[2,3 d]pyrimidine [1] |
?-sitosterol [1] |
?-thalassaemia [1] |
ACE 2 [1] |
ACE protein, human; dipeptidyl carboxypeptidase; brain hemorrhage; brain ischemia; cerebrovascular accident; comparative study; enzymology; female; gene deletion; gene expression regulation; genetic polymorphism; genetic predisposition; genetics; genotype; human; male; metabolism; middle aged; Brain Ischemia; Female; Gene Deletion; Genetic Predisposition to Disease; Genotype; Humans; Intracranial Hemorrhages; Male; Middle Aged; Mutagenesis, Insertional; Peptidyl-Dipeptidase A; Polymorphism, Gene [1] |
ACE2 [2] |
acetic acid [1] |
Acetylcholine [1] |
acetylcholinesterase [1] |
Acetylsalicylic Acid [1] |
acetylsalicylic acid [1] |
acetylsalicylic acid; alteplase; angiotensin receptor antagonist; anticoagulant agent; antihypertensive agent; antithrombocytic agent; beta adrenergic receptor blocking agent; calcium channel blocking agent; clopidogrel; dipeptidyl carboxypeptidase; dipeptidyl carboxypeptidase inhibitor; hydroxymethylglutaryl coenzyme A reductase inhibitor; thiazide diuretic agent; biological marker; anticoagulant therapy; antihypertensive therapy; Article; cerebrovascular accident; controlled clinical trial (to [1] |
Achaea janata [1] |
Acid β-glucosidase glucocerebrosidase enzyme [1] |
Actin [1] |
Acute toxicity [1] |
Adenine [1] |
Adenomyosis [1] |
Adenosine Triphosphate [1] |
Adipogenesis [1] |
Adipokines [1] |
Adiponectin [1] |
Adipoq Gene [1] |
adjuvants [1] |
Adolescent [2] |
Adult [11] |
adult [1] |
Adult Brain Hemorrhage [2] |
adult; Article; brain ischemia; DNA polymorphism; female; genetic analysis; genetic association; human; Indian; major clinical study; male; pathogenesis; aged; cerebrovascular accident; computer assisted tomography; DNA sequence; ethnology; genetic polymorphism; genetic predisposition; genetics; genotype; geography; India; ischemia; middle aged; neurology; nuclear magnetic resonance imaging; risk factor; Aged; Female; Genetic Predisposition to Disease; Genotype; Geography; Humans; India; Ischemi [1] |
Advanced delivery system [1] |
adverse event [1] |
AECOPD [1] |
afatinib [1] |
Aged [5] |
aged [2] |
Aged Case Control Study [1] |
Aggregation [1] |
Aging [3] |
aglyconic [1] |
agriculture [1] |
Ailment [1] |
Airway hyperresponsiveness [1] |
Alanine [1] |
Alanine Aminotransferase [1] |
albendazole [1] |
Albumin [1] |
albumin denaturation and membrane stabilization assay [1] |
AlCl3 [1] |
alcohol consumption [1] |
Alcohol-induced liver disease [1] |
Algorithm [1] |
Alignments [1] |
Alkaloids [1] |
Allele [1] |
allele [1] |
Allele Body Mass [1] |
Allelic heterogeneity [1] |
Alpha2 Integrin [1] |
Alpinetin [1] |
Alterations [1] |
altered expression [1] |
Alternative treatment [1] |
Alu [1] |
Alzheimer's disease [8] |
Alzheimer’s disease [1] |
Alzheimer�s disease [5] |
alzheimer�s disease [1] |
Amerindians [1] |
amide [1] |
Amino acids [1] |
aminopeptidase N [1] |
Amomum subulatum [1] |
AMP-Activated Protein Kinases [1] |
AMPK [2] |
Ampk Signaling [1] |
Amygdala [1] |
Amyloid beta [4] |
Amyloid-? plaques [1] |
anaemia [1] |
anagrelide [1] |
ANCA associated vasculitis (AAV) [1] |
ANCA-associated vasculitis [1] |
ancient tea plantations [1] |
ANG modulators [1] |
ANG-Er? pathway [1] |
ANG-PI3K/Akt pathway [1] |
ANG-TIE2 pathway [1] |
ANG-VEGF inhibitors [1] |
Angelica Gigans Extract [1] |
Angiogenesis [2] |
Angiopoietins [1] |
Angiotensin (1�7) [1] |
Angiotensin II [1] |
anilinoquizoline [1] |
animal [1] |
Animal Cell [2] |
Animal cell [1] |
Animal cell beta sheet [1] |
Animal experi [1] |
Animal Experiment [2] |
Animal Model [3] |
animal models [2] |
Animal Tissue [2] |
Animals [2] |
Ank3 Gene Autoimmune Disease [1] |
Ankyrin [1] |
Ankyrin 3 [1] |
ANNOVAR [1] |
anthelminthic [1] |
anthocyanin [1] |
Anthocyanins [1] |
Anthracyclines [1] |
anti fungal drugs [1] |
anti-angiogenesis [1] |
Anti-bacterial [1] |
Anti-cancer [2] |
Anti-glioblastoma effects [1] |
anti-inflammation [1] |
Anti-inflammatory [2] |
anti-inflammatory [3] |
anti-metastasis [2] |
Anti-oxidant [1] |
Anti-proliferative [1] |
anti-sickling [1] |
Anti-urolithiatic [1] |
Antibacterial [1] |
Antibacterial Activity [1] |
Antibiotic Agent [1] |
Anticancer [4] |
anticancer [1] |
Anticancer activity [2] |
Anticancer agents [2] |
anticancer drugs [1] |
anticoagulant agent [1] |
Anticonvulsive Agent [1] |
Antifungal [4] |
antifungal compounds [1] |
Antimalarial [1] |
Antimetastatic [1] |
Antimicrobial [2] |
Antimicrobial activity [1] |
Antimicrobial effects [1] |
Antineoplastic activity [1] |
antineoplastic activity [1] |
Antineoplastic agent [2] |
antineoplastic agent [1] |
Antioxidant [7] |
antioxidant [3] |
Antioxidant activity [2] |
Antioxidant Activity Case Control Study [1] |
Antioxidant enzymes [1] |
antioxidant; bixin; glucose; insulin; taurine; unclassified drug; antioxidant activity; atherosclerosis; chronic inflammation; diabetes mellitus; diabetic cardiomyopathy; diabetic complication; diabetic nephropathy; diabetic neuropathy; diabetic retinopathy; disease association; disease marker; editorial; endothelial dysfunction; glucose transport; heat stroke; human; insulin resistance; malignant neoplastic disease; metabolic regulation; non insulin dependent diabetes mellitus; oxidative stress [1] |
antioxidants [2] |
antiplatelet drugs [1] |
antiproliferation [1] |
Antiproliferative activity [1] |
antiproliferative activity [1] |
Antipsychotics [1] |
antitumor activity [1] |
Antiviral [1] |
Antiviral medications [1] |
Anxiety [1] |
anxiety [1] |
Aortic stenosis [1] |
APE1/Ref-1 [1] |
Apert syndrome [2] |
ApoC-III [1] |
Apocynin [1] |
Apoe Protein, Human [1] |
Apolipoprotein E [1] |
Apolipoprotein E2 [1] |
Apolipoprotein E3 [1] |
Apolipoprotein E4 [1] |
Apoptosis [9] |
apoptosis [4] |
Apoptosis activation [1] |
apoptosis and cell cycle [1] |
apoptosis and cell cycle arrest [1] |
apoptosis assay [1] |
Apoptosis Cardiac Muscle Cell [1] |
Applications [1] |
Arachidonic Acid [1] |
Artemisinin [1] |
Arthritis [1] |
Article [6] |
articular chondrocytes [1] |
Artificial Diet [1] |
Artificial intelligence [2] |
Asafoetida [1] |
ASD [1] |
Asian [1] |
Asian Continental Ancestry Group [3] |
Asian continental ancestry group [1] |
Asian Indians [1] |
Asians [1] |
Asocoumarin A, 14?- demethylase [1] |
Aspirin [2] |
Aspirin Resistance [2] |
Association [1] |
Asteraceae family [1] |
Asthma [1] |
AT<sub>1</sub> receptor [1] |
AT<sub>2</sub> receptor [1] |
ATF6 [1] |
ATP [1] |
Atp8B2 Gene [1] |
ATR protein [1] |
attention-deficit hyperactive disorder [1] |
Aurovertin [1] |
Autoimmunity [1] |
autoimmunity [1] |
Autophagic cargo [1] |
Autophagy [2] |
autopsy [1] |
Autosomal Dominant Inheritance [1] |
Axl [1] |
Azole [1] |
B-cell activating factor (BAFF) [1] |
Bacillus thuringiensis [1] |
Bacopa monnieri [2] |
Bacterial Growth [1] |
Bacterial Immunity [1] |
Bacterial Load [1] |
Bacterial Viability [1] |
Bacterial Virulence [1] |
Bactrocera Cucurbitae [1] |
Basal ganglia [1] |
Base Sequence [1] |
Bayes Theorem [1] |
Bayes theorem [1] |
BC [1] |
BCG vaccine [2] |
BCL-2 [1] |
Bcl-2 [1] |
Bedaquiline [1] |
Behavior [1] |
Behavioral Pharmacology [1] |
behavioural analysis [1] |
Benzimidazole [1] |
Benzoxazepines [1] |
Berberine [1] |
Beta-cell (?-cell) [1] |
Betaine [1] |
betaine [1] |
Big data [1] |
bilayer tablet [1] |
Bilirubin [1] |
Biliverdin [1] |
Binding affinity [1] |
binding mode analysis [1] |
binding site [1] |
Bioactive compounds [1] |
bioactive compounds [1] |
Bioavailability [1] |
Bioceramics [1] |
Biochemical [1] |
biochemical estimation [1] |
biocontrol [1] |
biodegradable [1] |
Bioenergetic therapy [2] |
Bioengineering [1] |
Bioethics [1] |
Biofilm [1] |
Biogenesis [1] |
Bioimaging [1] |
Bioinformatics [2] |
bioinformatics [1] |
Biological activities [1] |
Biological Marker [1] |
Biomarker [1] |
biomarker [3] |
Biomarkers [1] |
Biomedical applications [1] |
biomedical applications [1] |
Biomolecules [1] |
Biotechnology [1] |
Blood [1] |
Blood brain barrier [2] |
Blood Glucose [1] |
Blood platelet [1] |
blood vessel tone [1] |
Blood-brain barrier [2] |
Blood�brain barrier [1] |
bms 690514 [1] |
Body Mass [1] |
body mass [1] |
Body Mass Index [1] |
Body Weight [1] |
Brahmi [1] |
Brain [2] |
brain [1] |
brain blood flow [1] |
brain cancer [1] |
brain cortex [1] |
brain infarction [1] |
Brain injury [2] |
brain injury [1] |
Brain Ischemia [3] |
Brain tumor [1] |
BRCA2 [1] |
Breast [1] |
Breast Cancer [5] |
Breast cancer [13] |
breast cancer [4] |
Breast cancers [1] |
Breast Neoplasms [1] |
breast tumor [1] |
Bulk heterojunction [1] |
C Reactive Protein [1] |
C reactive protein; biological marker; C reactive protein; adult; Article; brain hemorrhage; brain ischemia; controlled study; female; gene frequency; genetic association; genetic polymorphism; genetic variability; genotype; human; Indian; major clinical study; male; promoter region; protein blood level; aged; blood; brain ischemia; Cerebral Hemorrhage; genetic polymorphism; genetics; health survey; India; metabolism; middle aged; procedures; Stroke; Adult; Aged; Biological Markers; Brain Ischem [1] |
C-reactive protein [1] |
C. elegans [1] |
Cadmium (Cd) [1] |
Caenorhabditis Elegans [1] |
Caenorhabditis Elegans Protein [1] |
Calcium [1] |
calcium [1] |
Calcium homeostasis [1] |
calcium; carbamazepine; copper; etiracetam; lamotrigine; magnesium; phenytoin; valproic acid; zinc; mineral; trace element; adolescent; Article; atomic absorption spectrometry; calcium blood level; comparative study; controlled study; copper blood level; drug tolerability; female; generalized epilepsy; groups by age; human; idiopathic disease; idiopathic intractable epilepsy; India; intractable epilepsy; magnesium blood level; major clinical study; male; trace metal blood level; zinc blood level [1] |
Camellia sinensis var. assamica [1] |
cAMP [1] |
camptothecin; messenger RNA; nutlin 3; protein p21; protein p53; regulator protein; short hairpin RNA; transducer of Cdc42 dependent actin assembly 1; unclassified drug; carrier protein; FNBP1L protein, human; messenger RNA; protein p53; Toca-1 protein, rat; TP53 protein, human; vesicular transport adaptor protein; animal experiment; Article; breast cancer; cancer cell culture; chromatin immunoprecipitation; controlled study; human; human cell; immunoblotting; immunohistochemistry; in vitro stud [1] |
Cancer [19] |
cancer [3] |
Cancer (malignancy) [1] |
cancer adjuvant therapy [1] |
cancer cell [1] |
Cancer cell signalling [1] |
cancer mortality [1] |
Cancer Prognosis [1] |
cancer progression [1] |
Cancer stem cells [1] |
Cancer Susceptibility [1] |
Cancer therapy [1] |
Candidate gene variants [1] |
canertinib [1] |
Carbamazepine [2] |
carcinogenesis [1] |
Carcinoma [1] |
Cardiac Remodeling [1] |
Cardioembolic Stroke [1] |
cardiometabolic traits [1] |
Cardiotoxicity [3] |
cardiotoxicity [1] |
Cardiovascular diseases [1] |
Caribbean [1] |
Case Control Study [3] |
Case Report [2] |
Case-Control Studies [1] |
Caspase [1] |
caspase [1] |
Caspases [2] |
Catalase [2] |
Catalysis [1] |
Caulerpa [1] |
Caulerpa taxifolia [2] |
Caulerpenyne [1] |
Caveolin [1] |
Ccdc85A Gene [1] |
Cd14 Antigen [1] |
CDH18 [1] |
Cdkn1A Protein, Rat [1] |
Celiac Disease [1] |
Celiac disease [3] |
celiac disease [3] |
Cell Culture [1] |
Cell Cycle [1] |
Cell cycle [1] |
cell cycle [1] |
Cell cycle arrest [1] |
Cell cycle progression [1] |
cell cycle protein 6 [1] |
Cell Cycle Proteins [1] |
Cell Damage [1] |
cell growth [1] |
Cell Invasion [1] |
cell invasion [1] |
Cell Line [1] |
Cell Migration [1] |
cell proliferation [1] |
Cell Receptor [1] |
Cell Size [1] |
cellular Signaling [1] |
Cerebral [1] |
cerebrovascular accident [1] |
CF [1] |
CHAC1 [3] |
ChaC2 [1] |
Chagas Disease [2] |
Chemoprevention [1] |
Chemoresistance [1] |
Chemotherapy [1] |
Chemotherapy-induced nausea and vomiting (CINV) [1] |
Child [6] |
child [1] |
ChIP-seq [1] |
Chitinase [1] |
cholecalciferol [1] |
chondrogenesis [1] |
Chromatin [1] |
Chromatin Immunoprecipitation [1] |
chromatin immunoprecipitation [1] |
Chromatography [1] |
chromosomal instability [1] |
chromosome [1] |
Chromosome 19Q [1] |
Chromosome 4 [1] |
Chromosome 6 [1] |
chromosome aberration [1] |
Chromosome Analysis [3] |
chromosome analysis [1] |
Chromosome Translocation [1] |
Chronic constriction injury [1] |
Chronic Periodontitis [1] |
Chronic periodontitis [1] |
cilostazol [1] |
CIP4 [1] |
Circular RNA [1] |
Cirrhosis [1] |
Citrullus colocynthis [1] |
Clinical [1] |
clinical [1] |
Clinical & epidemiological profile [1] |
Clinical Article [1] |
Clinical Assessment Tool [1] |
clinical effectiveness [1] |
clinical evaluation [1] |
Clinical Feature [1] |
clinical feature [1] |
Clinical outcome [1] |
clinodactyly [1] |
Clopidogrel [1] |
clove [1] |
CNS disease [1] |
Co-occurrence [1] |
CoCl<sub>2</sub> [1] |
Cognitive decline [1] |
cognitive deficit [1] |
Cohort Analysis [3] |
Cohort Studies [1] |
Collagen [1] |
Collagen cross-linking [1] |
colon cancer [1] |
Colored wheat [1] |
Comorbidities [1] |
Comorbidity [1] |
Comparative Study [2] |
Comparative study [1] |
Computer Model [1] |
Computing technologies [1] |
Con [1] |
Concentration Response [1] |
condensin [1] |
Confidentiality [1] |
connectivity [1] |
Controlled Study [13] |
Controlled study [1] |
controlled study [2] |
COPD [5] |
cornea [1] |
Corona virus [1] |
Coronary artery disease risk [1] |
Coronavirus [1] |
coronavirus disease-19 [1] |
Cortactin [1] |
Cortex [1] |
Corticosteroid [1] |
Corticosterone [1] |
COVID-19 [8] |
COVID-19-associated mucormycosis [1] |
COVID19 [1] |
Cox 1 Gene [1] |
Cox 2 Gene [2] |
cp 724714 [1] |
CpG islands [1] |
craniofacial dysostosis [1] |
Craniosynostosis [2] |
CRF-1 [1] |
CRISPR/Cas [1] |
CRISPR/Cas9 [3] |
cross-linking [1] |
cry toxin [1] |
Crystal structure [1] |
Cucurbita pepo [1] |
Cucurbitacins [1] |
cudc 101 [1] |
culinary spices [1] |
Curcuma longa [3] |
Curcumin [1] |
curcumin [1] |
cyclic AMP phosphodiesterase [1] |
cyclic GMP [1] |
Cyclin dependent kinase [1] |
Cyclin dependent kinase 1 [1] |
Cyclin dependent kinase 12 [1] |
Cyclin dependent kinase 13 [1] |
Cyclin dependent kinase 16 [1] |
Cyclin dependent kinase 2 [1] |
cyclin dependent kinase 2 [1] |
Cyclin dependent kinase 4 [1] |
Cyclin dependent kinase 5 [1] |
Cyclin dependent kinase 6 [1] |
Cyclin dependent kinase 7 [1] |
Cyclin dependent kinase 8 [1] |
Cyclin dependent kinase 9 [1] |
Cyclin Dependent Kinase Inhibitor 1A [1] |
Cyclin dependent Kises [1] |
cyclin E [1] |
Cyclindependent kinase inhibitor [1] |
Cyclooxygenase 1 [1] |
CYP19 polymorphism genetic risk [1] |
Cysteine Derivative [1] |
cytochrome P450 [1] |
Cytogenetics [1] |
Cytokine Release [1] |
Cytokine storm [1] |
Cytokines [2] |
cytokines [3] |
Cytosine [2] |
Cytoskeleton protein [1] |
Cytotoxicity [2] |
Dacarbazine [1] |
dacomitinib [1] |
Daf-12 Protein, C Elegans [1] |
DAF-16 [1] |
Daf-16 Protein, C Elegans [1] |
Daf-2 Protein, C Elegans [1] |
Data analysis [1] |
Data mining [1] |
Data science [1] |
DCA [1] |
DDR1 [2] |
De novo sequencing [1] |
Decorin [1] |
delivery vehicles [1] |
demography [1] |
denbufylline [1] |
Dendrimers [2] |
Depression [3] |
Derivatives [1] |
derivatives drugs [1] |
Detection [1] |
Detoxification [1] |
developmental disorder [1] |
Diabet [1] |
Diabetes [4] |
diabetes [3] |
Diabetes Mellitus [1] |
Diabetes mellitus [2] |
diabetes mellitus [2] |
Diabetes Mellitus, Type 1 [1] |
Diabetes Mellitus, Type 2 [2] |
Diabetic Cardiomyopathy [1] |
Diabetic complications [2] |
diabetic complications [1] |
Diabetic foot [1] |
Diabetic nephropathy [1] |
Diabetic neuropathy [2] |
diabetic neuropathy [1] |
Diabetic Patient [1] |
Diabetic retinopathy [1] |
Diagnosis [2] |
diagnosis [2] |
Diagnostic Accuracy [1] |
Diagnostics [1] |
Diastolic Blood Pressure [1] |
Dielectric heating [1] |
Diet [2] |
diet [1] |
Diet Restriction [1] |
Diet, High-Fat [1] |
Diet, Mediterranean [1] |
dietary supplement [1] |
Dietary Supplements [1] |
Differential expression [1] |
Differential methylated regions [1] |
differential scanning calorimetry (DSC) [1] |
Diffusion [1] |
Digestive Enzymes [1] |
Diopathic generalized epilepsy [1] |
Dipeptidyl peptidase-4 [1] |
dipeptidyl peptidase-4 [1] |
diphtheria pertussis tetanus vaccine [1] |
Diphtheria-Tetanus-Pertussis Vaccine [1] |
dipyridamole [1] |
Directory [1] |
Disability [1] |
disability-adjusted life year [1] |
Discoidin domain receptor [1] |
Disease Association [2] |
disease burden [1] |
Disease Course [1] |
Disease Marker [1] |
Disease model [1] |
disease model [1] |
Disease Models, Animal [1] |
Disease severity [1] |
disease severity [1] |
Dissociation constant [1] |
DLC1 & PKC [1] |
DLC1 & PKCζ [1] |
Dmrta1 Gene [1] |
Dna [5] |
Dna (Apurinic Or Apyrimidinic Site) Lyase [1] |
DNA base damage [1] |
DNA binding [1] |
Dna Damage [1] |
DNA fragmentation [1] |
Dna Isolation [1] |
DNA methylation [1] |
Dna Methylation [1] |
Dna Polymorphism [1] |
Dna Primers [1] |
Dna Replication [1] |
Dna Sequence [1] |
Dna-Binding Proteins [1] |
DNMT 1 [1] |
docking [2] |
docking study [1] |
dopamine [1] |
Dose Response [1] |
Doxorubicin [2] |
doxorubicin [1] |
Drosophila Protein [1] |
Drug [1] |
Drug activity [1] |
Drug binding [1] |
Drug carriers [1] |
Drug delivery [2] |
Drug delivery system [1] |
Drug design [1] |
drug designing [1] |
Drug determination [1] |
drug development [1] |
Drug discovery [1] |
drug discovery [2] |
Drug Effect [1] |
Drug Glucuronidation [1] |
Drug molecules [1] |
Drug Resistance [1] |
Drug structure [1] |
Drug target [1] |
Drugs [2] |
drugs synthesis [1] |
DU4475 cell line [1] |
Dual Antiplatelet Therapy [1] |
dual antiplatelet therapy [1] |
Dual inhibitors [1] |
Duodenal mucosa [1] |
Dutch [1] |
dwarfism [1] |
Dynamin [1] |
dynamin [1] |
Dysthymia [1] |
E-pharmacophore [1] |
Early Diagnosis [1] |
earthworms [1] |
EGFR [2] |
egg [1] |
Electron transport system [1] |
Electrophoretic [1] |
Emicerfont [1] |
ENaC [1] |
endocytosis [1] |
Endometriosis [1] |
Endopeptidase Clp [1] |
Endopeptidase La [1] |
Endoplasmic reticulum stress [2] |
endothelial leukocyte adhesion molecule 1; endothelial leukocyte adhesion molecule 1; SELE protein, human; adult; Article; brain hemorrhage; brain ischemia; comparative study; controlled study; disease association; DNA polymorphism; female; gene frequency; genotype; human; major clinical study; male; polymerase chain reaction; restriction fragment length polymorphism; brain hemorrhage; brain ischemia; cerebrovascular accident; genetic association; genetic polymorphism; genetic predisposition; ge [1] |
energy metabolism [1] |
Energy Yield [1] |
environmental factor [1] |
Enzymatic degradation [1] |
Enzyme Inhibition [1] |
enzyme inhibitor [1] |
Enzyme Linked Immunosorbent Assay [1] |
Eor-1 Protein, C Elegans [1] |
eotaxin; high density lipoprotein cholesterol; low density lipoprotein cholesterol; triacylglycerol; CCL11 protein, human; eotaxin; adult; alcohol consumption; alcoholism; artery occlusion; Article; brain atherosclerosis; brain hemorrhage; brain ischemia; cholesterol blood level; controlled study; diabetes mellitus; DNA isolation; DNA polymorphism; family history; female; gene frequency; genetic variability; genotype; human; hypertension; Indian; major clinical study; male; polymerase chain reac [1] |
epertinib [1] |
Eph receptor [1] |
ephrin [1] |
Epidemiology [1] |
epidemiology [2] |
epidermal growth factor receptor [1] |
Epidermal Growth Factor Receptor 2 [1] |
epidermal growth factor receptor 2 [1] |
epidermal growth factor receptor kinase inhibitor [1] |
Epigallocatechin Gallate [1] |
Epigenetic changes [1] |
Epigenetic factors [1] |
Epigenetic instability [1] |
Epigenetics [2] |
epigenetics [1] |
Epigenomics [1] |
Epilepsy [4] |
epilepsy [1] |
epileptogenesis [1] |
ER [1] |
ER stress [1] |
ER-mitochondria calcium signaling [1] |
Erbb2 Protein, Human [1] |
Erythrocyte [1] |
Erythroid precursors [1] |
essential oil [1] |
Esterase [1] |
Estrogen [1] |
Estrogen Receptor Alpha [1] |
Ethnic Group [2] |
Ethnicity [1] |
Ethosomal-gel [1] |
Ethosomes [1] |
Etiopathology [1] |
Etoposide [1] |
Eucalyptus tereticornis [1] |
Europe [1] |
European [1] |
Excitotoxicity [6] |
excitotoxicity [1] |
Exome sequencing [2] |
Exon [1] |
exon [1] |
Exosome [1] |
Exosomes [1] |
exosomes [1] |
Extracellular Matrix [1] |
extrinsic pathway [1] |
EZH2 [1] |
Fam60A Gene [1] |
Family History [1] |
family study [1] |
Fasudil [1] |
fatty acid binding protein [1] |
Fatty Acid-Binding Proteins [1] |
FBP17 [1] |
Fear memory [1] |
Female [17] |
female [3] |
Ferric Reducing Antioxidant Power Assay [1] |
Fertility [1] |
fertility [1] |
Ferulic acid [1] |
ferulic acid [1] |
fetal hemoglobin (HbF) [1] |
Fetuin [1] |
fetuin-A [1] |
FGF-21 [2] |
FGFR2 gene [2] |
Fibrinogen Receptor [1] |
Fibrosis [4] |
fibrosis [2] |
Filgrastim [1] |
fixed-dose combination [1] |
Flavonoid [1] |
Flavonoids [4] |
flavonoids [1] |
fluorescence [1] |
Foetal haemoglobin [1] |
FoF1 ATP synthase inhibitor [1] |
Fok1 polymorphism [1] |
Folic acid [2] |
Follow Up [1] |
forensics [1] |
Forkhead Transcription Factor [1] |
formin (protein) [1] |
Formin Binding Protein 17 [1] |
formin binding protein 17 [1] |
Formins [1] |
FOXO [1] |
Foxo Protein, Drosophila [1] |
FOXO1 [1] |
Foxo3 Protein, Human [1] |
Frameshift [1] |
Francisella Tularensis [1] |
Free radical [2] |
Free radicals [3] |
Friedreich Ataxia [1] |
Fructose [1] |
fructose [1] |
FTIR [1] |
function [2] |
Functional foods [1] |
Functional magnetic resonance imaging [1] |
Functions [1] |
Funding [1] |
fungal co infection [1] |
fungi [1] |
Fusion-fission proteins [1] |
G-protein-coupled estrogen receptor-1 (GPER) [1] |
Ga Binding Protein [1] |
GABA [1] |
Gabapentin [1] |
Gabra6 Gene [1] |
Gabra6 Protein, Human [1] |
Gadolinium oxide nanocuboides [1] |
Gain-of-function [1] |
Galactomannase [1] |
Galactose [1] |
Galangin [1] |
garlic [1] |
Gastrointestinal Hemorrhage [1] |
Gaucher Disease (GD) [1] |
GC-MS [1] |
GC�MS [1] |
Gene [3] |
gene amplification [1] |
Gene Deletion [1] |
Gene delivery [1] |
Gene editing [1] |
Gene Expression [4] |
Gene Expression Regulation [1] |
Gene Frequency [8] |
Gene Interaction [1] |
Gene Locus [7] |
Gene Mapping [1] |
Gene Mutation [2] |
gene mutation [1] |
gene silencing [1] |
Gene therapy [2] |
gene therapy [1] |
Gene variants [1] |
Gene Variants, [1] |
gene-gene interactions [1] |
Generalized Epilepsy [3] |
Genes [1] |
Genetic Analysis [2] |
Genetic Association [10] |
genetic association [3] |
Genetic Counseling [1] |
Genetic diseases [2] |
Genetic Disorder [2] |
genetic epidemiology [1] |
Genetic Generalized Epilepsy [1] |
Genetic Heterogeneity [1] |
Genetic heterogeneity [1] |
Genetic Linkage [2] |
Genetic Marker [1] |
genetic marker [1] |
genetic models [1] |
genetic modifiers [1] |
Genetic Polymorphism [4] |
Genetic polymorphism [1] |
Genetic polymorphisms [1] |
Genetic Predisposition [4] |
Genetic Predisposition To Disease [1] |
Genetic Risk [4] |
Genetic Screening [1] |
Genetic Susceptibility [4] |
genetic susceptibility [1] |
Genetic Variability [6] |
Genetic variant [1] |
genetic variant [1] |
Genetic variants [1] |
Genetic Variation [3] |
Genetics [4] |
genetics [3] |
Genipin [1] |
Genom [1] |
Genome Analysis [1] |
genome editing [2] |
genomewide association [1] |
Genomic alterations [1] |
Genomic Alterations, [1] |
genomic DNA; hemoglobin F; hemoglobin gamma chain; hemoglobin F; hemoglobin gamma chain; adolescent; adult; Article; blood transfusion; controlled study; disease severity; gene; gene expression; gene frequency; genetic association; genetic polymorphism; genetic variability; genotype; growth retardation; hemoglobin blood level; human; major clinical study; onset age; sickle cell anemia; splenectomy; thalassemia major; Xmn1 gene; allele; Anemia, Sickle Cell; beta-Thalassemia; child; female; geneti [1] |
Genomics [1] |
genomics [1] |
Genotype [8] |
genotype [1] |
Genotype Phenotype Correlation [1] |
Genotypes [1] |
Germline variations [1] |
Gerotarget [1] |
gestational diabetes [1] |
glass transition [1] |
Glial cells [1] |
gliflozin [1] |
Gliflozins [1] |
glioblastoma [1] |
Glioma [1] |
Global Burden of Disease [2] |
global disease burden [2] |
Global Health [2] |
global health [2] |
Global hypomethylation [1] |
GLP-1 [1] |
GLP-1RAs [1] |
Glucose [1] |
Glucose Blood Level [2] |
Glucuronosyltransferase [1] |
Glutamate [1] |
Glutamate Decarboxylase 65 [1] |
Glutamate Decarboxylase 67 [1] |
Glutathione [1] |
glutathione [1] |
Glutathione Peroxidase [1] |
glyceraldehyde 3 phosphate dehydrogenase [1] |
Glycolysis [1] |
Glycosylation [1] |
Glycylcysteinylcysteine [1] |
Gnflammatory markers [1] |
Gonadal hormone [1] |
gonadotropin [1] |
Goniothalamus wynaadensis Bedd [1] |
Government Regulation [1] |
GPx1−/−, P47phox−/−) [1] |
Granulocyte-colony stimulating factor [1] |
Granulocyte-colony stimulating factor-receptors [1] |
Granulomatosis with polyangiitis [1] |
granulomatosis with polyangiitis [1] |
Granulomatosis with polyangiitis (GPA) [1] |
Graphene [1] |
Growth disorders [1] |
Growth factors [1] |
growth regulation [1] |
growth retardat [1] |
GSA (Global Screening Array) [1] |
GSK-3? [1] |
Guanine [1] |
Gut microbiota [1] |
gut microbiota [1] |
Gut-lung axis [1] |
GWAS [2] |
H3K27 [1] |
H<sub>2</sub>S [1] |
Haloperidol [1] |
haloperidol [1] |
Haploinsufficiency [1] |
Haplotype [5] |
Haplotypes [1] |
HbA1c [1] |
HD- Huntington's disease [1] |
HDAC functions [1] |
HDAC inhibitors [1] |
HDAC knockout study [1] |
Headache [2] |
Health Care Cost [1] |
Health Care Facility [1] |
Health Care System [1] |
Health Center [1] |
Health Risk [1] |
Health Service [1] |
health survey [1] |
Healthcare [1] |
Heart failure [1] |
heart function [1] |
Heart Ventricle Hypertrophy [1] |
Heat Shock Protein 70 [1] |
Heat Shock Protein 90 [1] |
Hedgehog [1] |
Hemagglutination [1] |
hemagglutination [1] |
Hematological [1] |
Hemithioindigos [1] |
hemoglobinopathy [1] |
Hepatic injury [1] |
Her2 [1] |
HER2 Overexpression [1] |
HER2 positive breast cancer [1] |
HER2-positive breast cancer [1] |
herbal medicines [1] |
herbicides [1] |
Heritability [1] |
heritability [1] |
Heterocyclic [2] |
Heterocyclic compounds [1] |
Heterozygote [1] |
High Density Lipoprotein Cholesterol [2] |
High throughput technologies [1] |
Hindi [1] |
Hip [1] |
Hip Circumference [1] |
Hippo [1] |
Hippocampus [1] |
Histological analysis [1] |
Histone [1] |
Histone deacetylase [1] |
Histone deacetylases [3] |
Histone Modification [1] |
Histopathology [3] |
Hla Dq2 Antigen [1] |
Hla Dq8 Antigen [1] |
HLA genes [1] |
Hla Typing [1] |
Homeostasis [1] |
Homeostasis Model Assessment For Beta Cell Function [1] |
Homeostasis Model Assessment Insulin Resistance [1] |
homing [1] |
Homocysteine [3] |
Homologous recombination [1] |
Hum [1] |
Human [24] |
human [6] |
Human Cell [3] |
human cell [1] |
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer [1] |
Human Genetics [1] |
human monkeypox (HMPX) [1] |
human tissue [1] |
Humans [7] |
Huntington's disease [4] |
Huntington�s disease [4] |
Huntington�s disease (HD) [1] |
Huntington�s Disorder [1] |
Hybridization [1] |
Hydrogen peroxide [1] |
hydroxymethylglutaryl coenzyme A reductase kinase [1] |
Hyper-phosphorylated Tau [1] |
hyperactivity [1] |
Hyperalgesia [1] |
Hypercoagulability [1] |
Hyperglycaemia [1] |
Hyperglycemia [1] |
hyperglycemia [2] |
Hyperhomocysteinemia [1] |
Hypotension [1] |
Hypoxia Inducible Factor 1Alpha [1] |
hypoxic condition [1] |
IBD [1] |
ID-Migraine [1] |
Idiopathic recurrent pregnancy loss [1] |
imidazole [2] |
imidazole drugs [1] |
Imine pyrazolopyrimidinone [1] |
Imine/amide-imidazole [1] |
Immobilization [1] |
Immune cells activation [1] |
Immunity [1] |
immunochip [1] |
immunochip association study [1] |
Immunocompetent Cell [1] |
Immunoglobulin Enhancer Binding Protein [1] |
Immunohistochemistry [1] |
immunohistochemistry [1] |
Immunologic agent [1] |
Immunological Antineoplastic Agent [1] |
Immunology [1] |
Immunomodulating Agent [1] |
Immunomodulation [2] |
immunomodulation [1] |
immunotherapy [1] |
In [1] |
in silico [2] |
In Vitro Study [2] |
in vitro study [1] |
In Vivo Stu [1] |
in vivo study [1] |
Inafm2 Gene [1] |
Indi [1] |
India [9] |
Indian [3] |
Indian herbs [1] |
Indian population [1] |
induced pluripotent stem cells [1] |
Inducible nitric oxide synthase [1] |
Infection [2] |
Infectious diseases [1] |
Infertility, Male [1] |
Infiltrating ductal carcinoma [1] |
Inflammation [12] |
inflammation [4] |
Inflammatory cascade [1] |
inflammatory markers [1] |
Informed consent [1] |
inhibitor [2] |
Inhibitor Of Apoptosis Protein [1] |
inhibitors [1] |
Innate Immunity [1] |
Inner Membrane [1] |
Insect Bioassay [1] |
Insulin [2] |
insulin dependent diabetes mellitus [1] |
Insulin Receptor [1] |
Insulin Receptor Substrate [1] |
Insulin Receptor Substrate 1 [1] |
Insulin Resistance [2] |
Insulin resistance [2] |
Insulin sensitivity [1] |
Insulin-like growth factors [1] |
Intellectual Impairment [1] |
Intellectual property rights [1] |
Inter-laboratory study [1] |
Interleukin 1Beta [1] |
Interleukin-1? [1] |
interleukins [1] |
internal validity [1] |
Interphase Chromosome Profiling [1] |
Intractable Epilepsy [1] |
intrinsic pathway [1] |
Intron [3] |
Invadopodia [1] |
Invasion [4] |
invasive ductal carcinoma [1] |
Investigational drug [1] |
Iodine [1] |
Ion channels [1] |
iPSC [1] |
IRE1 [1] |
Iron superoxide dismutase [1] |
Irs 1 [1] |
Irs1 Protein, Human [1] |
Ischemia/reperfusion [1] |
Ischemic preconditioning [1] |
Ischemic Stroke [2] |
Ischemic stroke [3] |
Isoflavone [2] |
IUGR [1] |
Japanese (People) [1] |
Joints [1] |
K/Na [1] |
Karyotype 46,Xy [1] |
kbp 5209 [1] |
Kcnq1 Protein, Human [1] |
keratoconus [1] |
Ki67 [1] |
KIBRA [1] |
Kibra [1] |
Kidney stone dissolution [1] |
Killer alga [2] |
kitchen [1] |
Kunitz-type protease inhibitor, plant [1] |
Kynurenine pathway [1] |
L-alanine [1] |
L-methionine [1] |
Labramia bojeri [1] |
Lamotrigine [1] |
Lapatinib [1] |
lapatinib [1] |
lead (Pb) [1] |
Lectin [1] |
lectin bioinformatics [1] |
Lectin like activity [1] |
Leigh [1] |
Leishmania donovani [1] |
Leucaena leucocephala galactomannan [1] |
leukemia [1] |
Life Expectancy [1] |
life expectancy [1] |
Life Style [1] |
lifestyle [1] |
Ligand [1] |
Linkage disequilibrium [1] |
Lipid [1] |
lipid diet [1] |
Lipid Metabolism [1] |
lipid metabolism [1] |
Lipid metabolisms [1] |
Lipogenesis [1] |
Liver [1] |
liver [1] |
Liver damage [1] |
Liver diseases [1] |
Liver function test [1] |
Liver functions [1] |
Liver tissue [1] |
LncRNA [2] |
lncRNA [2] |
lncRNA MIR503HG [1] |
LncRNAs [1] |
locus specific primers [1] |
Long COVID [1] |
Low Density Lipoprotein Cholesterol [2] |
Lung cancer [1] |
lung cancer [3] |
Lung diagnostics [1] |
Lung injury [1] |
Luteolin [1] |
luteolin [1] |
Lymphocyte Culture [1] |
Lyngbya [1] |
Lysosomal Storage Disorders (LSD) [1] |
M [1] |
Machine learning [1] |
macrocephaly [1] |
Macronutrients [1] |
macrophage polarization [1] |
macrophage targeting [1] |
macrophages [1] |
Magnetic nanoparticles [1] |
Magnetic resonance imaging [1] |
main protease [2] |
Major Clinical S [1] |
Major Clinical Study [9] |
major clinical study [1] |
Major depressive disorder [1] |
major depressive disorder [1] |
Malaria [1] |
Male [16] |
male [4] |
Male breast cancer [1] |
Male Infertility [1] |
male infertility [1] |
malignant neoplasm [1] |
Malnutrition [2] |
Malonaldehyde [1] |
Mammalian Target Of Rapamycin [1] |
Managed Care [1] |
management [1] |
Mannose [1] |
Marine alga [2] |
Marine algae [1] |
marketed drugs [1] |
mass spectrometry [1] |
Maternal factors [1] |
Maternal Uniparental Disomy of chromosome 7 [1] |
MCF-7 cell line [1] |
MD simulation [2] |
MDA-MB-157 cell line [1] |
Mda-Mb-231 Cell Line [1] |
MDAMB453 [1] |
Mean platelet volume [1] |
Measles Vaccine [1] |
measles vaccine [1] |
mechanism of action [1] |
Medical Research [1] |
Medical Society [1] |
Medicinal plant [1] |
Mediterranean diet [1] |
Melatonin 1 Receptor [1] |
Melittin [1] |
Memory [1] |
Mendelian randomization [1] |
Mendelian Randomization Analysis [1] |
Mendelian randomization analysis [1] |
MERS [1] |
Mesenchymal stem cells [1] |
mesenchymal stem cells [2] |
Messenger Rna [1] |
Messenger Rna Precursor [1] |
Meta Analysis [2] |
meta analysis [1] |
Meta Analysis (Topic) [1] |
Meta transcriptomics [1] |
Meta-analysis [7] |
meta-analysis [7] |
Meta-Analysis Asb3 Gene [1] |
Metabolic reprogramming [2] |
metabolic reprogramming [1] |
Metabolism [5] |
metabolism [2] |
Metagenomics [2] |
Metastasis [13] |
methenamine [1] |
Methionine [1] |
methionine [1] |
Methionine restriction [1] |
Methionine supplementation [1] |
methylation defects [1] |
Methyltransferase [1] |
methyltransferase [1] |
Mice (MnSODtg [1] |
micro RNAs [1] |
Microarrays [1] |
Microbial dynamics [1] |
Microbial dysbiosis [1] |
Microbiome [2] |
microbiome [2] |
Microcephaly [1] |
Microglia [1] |
microglia [1] |
Micronutrient [1] |
Micronutrients [1] |
Microrna [1] |
microRNA [1] |
Microrna 181A [1] |
Microrna 30C [1] |
microRNAs [2] |
Microvascular complications [2] |
Microwave irradiation [1] |
Middle Aged [2] |
Middle East [1] |
midgut [1] |
Migraine [2] |
migraine [2] |
Migration [1] |
Milrinone [1] |
milrinone [1] |
Minerals [1] |
Mir4686 Gene [1] |
Mirn181 Microrna, Rat [1] |
Mirn30 Microrna, Rat [1] |
miRNA [8] |
MiRNAs [1] |
miRNAs [4] |
Misfolding [1] |
Mito K<sub>ATP</sub> [1] |
Mito-miRs [1] |
Mitochondria [12] |
mitochondria [1] |
mitochondrial biogenesis [1] |
Mitochondrial changes [1] |
Mitochondrial dynamics [1] |
Mitochondrial Dysfunction [2] |
Mitochondrial dysfunction [4] |
mitochondrial dysfunction [1] |
Mitochondrial medicine [2] |
Mitochondrial miRNA [1] |
Mitochondrial Protein [1] |
Mitochondrial protein [1] |
mitogenesis [1] |
Mitophagy [2] |
Modulation [1] |
Molecular Diagnosis [1] |
Molecular docking [4] |
molecular docking [4] |
molecular dynamics [1] |
Molecular dynamics simulation [1] |
Molecular Genetics [1] |
Molecular mechanism [1] |
Molecular mechanisms [1] |
Molecular modeling [2] |
Molecular modelling [1] |
Molecular pathways [1] |
molecular pathways [1] |
Molecular weight [1] |
Monkeypox [2] |
monkeypox virus (MPXV) [1] |
Monogenic inherited epilepsies [1] |
MOPD type II [2] |
Moringa oleifera [1] |
mortality [1] |
Mouse [1] |
Movement disorders [1] |
moxifloxacin [1] |
MPV [1] |
MPXV pathophysiology [1] |
MRI [1] |
mRNA [1] |
mRNA vaccine [1] |
Mtnr1B Protein, Human [1] |
MTOR [1] |
mTOR [1] |
MTT [1] |
MTT assay [1] |
mubritinib [1] |
Mucormycosis [1] |
mucormycosis [1] |
Multifactor Dimensionality Reduction [1] |
Multiphoton Microscopy [1] |
Multiple Linear Regression Analysis [1] |
Multiple sclerosis [2] |
multiple sclerosis [1] |
Muscular dystrophy [1] |
Mutant [1] |
Mutant p53 [1] |
Mutation [1] |
mutation [1] |
Mutations [4] |
Myeloperoxidase [1] |
myeloperoxidase [1] |
myocardial hypertrophy [1] |
myocardial injury [1] |
Myoclonus Seizure [1] |
Myogenic progenitor [1] |
n [4 [3 chloro 4 (3 fluorobenzyloxy)anilino] 6 q [1] |
N-heterocycles [1] |
nAChR/Nrf2/HO-1 pathway [1] |
NADPH oxidase [1] |
NAFLD [1] |
Nano-carrier [1] |
Nanoformulation [1] |
Nanomaterials [1] |
Nanomedicine [2] |
Nanoparticle [1] |
Nanoparticles [5] |
nanoparticles [2] |
Nanosponges [1] |
Nanotheranostics [1] |
NASH [1] |
National Iodine Deficiency Disorders Control Programme [1] |
natural molecules [1] |
natural phytochemicals [1] |
natural plants [1] |
Natural product [1] |
Natural products [3] |
NCI-H1299 cell line [1] |
Necrosis [1] |
nephropathy [1] |
nephrotoxicity [1] |
nerolidol [1] |
Nerve Degeneration [2] |
nerve injury [1] |
NETosis [1] |
network pharmacology [1] |
Neurodegeneration [4] |
neurodegeneration [3] |
Neurodegenerative and cardiovascular diseases [1] |
Neurodegenerative diseases [2] |
Neurodegenerative disorder [1] |
Neurodegenerative disorders [1] |
neurodegenerative disorders [1] |
neurodevelopmental disorder [1] |
Neurofibrillary tangles [1] |
neurogenesis [1] |
Neuroimaging [1] |
Neuroinflamamation [1] |
Neuroinflammation [4] |
neuroinflammation [3] |
Neurological diseases [2] |
Neurological disorders [1] |
neuronal death [2] |
Neuronal injury [1] |
Neurons [1] |
neurons [1] |
Neuropathic pain [2] |
neuropathic pain [1] |
Neuroprotection [3] |
neuroprotection [3] |
neuroprotective effect [1] |
Neuroprotective effects [1] |
Neuropsychiatric diseases [1] |
neurotherapeutics [1] |
Neurotoxicity [1] |
Neurotransmission [1] |
neurotransmission [1] |
Neurotransmitters [1] |
neurotransmitters [1] |
Next Generation Sequencing [1] |
NF-kB [1] |
NF?B [1] |
NIDDCP [1] |
Nitric Oxide [1] |
Nitric oxide [3] |
NMDA receptor [1] |
Nociception [1] |
Non human [1] |
Non Insulin Dependent Diabetes Mellitus [4] |
non insulin dependent diabetes mellitus [2] |
Non-alcoholic Fatty Liver Disease [1] |
Non-alcoholic steatohepatitis [1] |
Non-Coding Rna [1] |
Non-coding RNA [1] |
Non-coding RNAs [2] |
non-dynamin GTPases [1] |
Non-HLA genes [1] |
Non-invasive imaging [1] |
non-syndromic hearing loss [1] |
Non-viral vectors [1] |
Non?coding RNA [1] |
nonalcoholic fatty liver [1] |
Nonalcoholic steatohepatitis [1] |
Nonhuman [1] |
nonhuman [2] |
Nonsense [1] |
Nonsteroid Antiinflammatory Agent [1] |
normoxic condition [1] |
North Africa [1] |
north Indians [1] |
noscapine [1] |
novel drug delivery [1] |
Novel missense alterations [1] |
Novel treatments [1] |
NRF-2 (Nuclear respiratory factor-2) [1] |
Nrf2/HO-1 [1] |
Nuclear Protein [1] |
Nucleotide Sequence [2] |
Nutrition [2] |
nutritional therapy [1] |
Obesity [5] |
obesity [2] |
Observational Study [1] |
Occupational hazard [1] |
Odds Ratio [1] |
odds ratio [1] |
Oligomycin [1] |
Omics [1] |
Onset Age [2] |
Optical coherence tomography [1] |
Oral-antidiabetic drugs [1] |
Orbital [1] |
Organelle crosstalk [1] |
organic semiconducting material [1] |
organic solar cell [1] |
organophosphate pesticides [1] |
origin recognition complex [1] |
Osteoporosis [1] |
osteoporosis [1] |
Outbreaks [1] |
overexpression/amplification [1] |
Oxidative and Nitrosative Stress [1] |
oxidative pressure [1] |
Oxidative Stress [5] |
Oxidative stress [18] |
oxidative stress [5] |
Oxidative stress markers [1] |
Oxidizing Agent [1] |
Oxidizing agent [1] |
OXPHOS [1] |
P53 [2] |
Pacific islands [1] |
Pain [1] |
Pancreas Islet Beta Cell [1] |
Pancreatic ?-cells [1] |
Pancreatic islet [1] |
Panic disorder [1] |
PAR-? [1] |
Parent- child trio study [1] |
Parent-child trio study [1] |
Parkinson's disease [5] |
Parkinson�s [1] |
Parkinson�s disease [2] |
Parkinson�s diseases (PD) [1] |
Patent [2] |
Pathogenesis [4] |
pathogenesis [1] |
pathogenic genetic variants [1] |
Pathogens [1] |
Pathology [1] |
pathology [1] |
Pathway [1] |
pathway [1] |
Patient-related risk factors [1] |
PCNT [2] |
PCOS [3] |
PCR [1] |
Pediococcus acidilactici BD16 [1] |
PEITC [2] |
Peltophorum dubium; [1] |
Pentylenetetrazole [1] |
pentylenetetrazole [1] |
Peptide [1] |
Peptides [1] |
pericentrin [1] |
Perinatal Period [1] |
PERK [1] |
Peroxidase [1] |
Peroxisome Proliferator Activated Receptor Gamma [1] |
Peroxynitrite [1] |
Peroxynitrous acid [1] |
Personalized medicine [1] |
Pexacerfont [1] |
pharmaceutical therapies [1] |
Pharmacodynamics [3] |
Pharmacogenetics [1] |
pharmacogenetics [1] |
Pharmacogenomics [1] |
pharmacogenomics [1] |
pharmacokinetic parameters [1] |
Pharmacokinetics [2] |
Pharmacological Activity [1] |
pharmacological activity [1] |
Pharmacological effects [1] |
pharmacology [1] |
Pharmacotherapy [1] |
Phenolics [1] |
phenotype [2] |
Phenytoin [2] |
phosphodiesterase [1] |
phosphodiesterase 4D; phosphodiesterase IV; platelet derived growth factor; small interfering RNA; unclassified drug; PDE4D protein, human; phosphodiesterase IV; arterial wall thickness; blood brain barrier; blood vessel permeability; brain ischemia; cardioembolic stroke; cell proliferation; ethnic difference; female; gene; gene frequency; genetic association; genetic epidemiology; genetic predisposition; genetic variability; genotype; haplotype; human; immunoreactivity; ligand binding; magnetic [1] |
phosphodiesterase inhibitor [1] |
phosphodiesterase IV inhibitor [1] |
phosphodiesterase V inhibitor [1] |
Phosphorylated tau [1] |
Phosphotransferase [1] |
phylogeny [1] |
physical activity [1] |
physical trauma models [1] |
phyto-pathogens [1] |
Phytochemical screening [1] |
Phytochemical, TMPRSS2 [1] |
Phytochemicals [3] |
phytoconstituents [1] |
PI3k/Akt [1] |
Pictet-Spengler reaction [1] |
Pictet-spengler reaction [1] |
Pictet-Spenglerase enzymes [1] |
Pictet-spenglerase enzymes [1] |
PIK3CA [1] |
Pirna [1] |
piroxicam [1] |
plant constituents [1] |
Plant Extract [1] |
plant extract [1] |
Plant Extracts [1] |
plant leaf [1] |
Plant Leaves [1] |
Plant lectin [1] |
Plant protein [1] |
plant root [1] |
Plant Roots [1] |
plant stem [1] |
Plasmodium falciparum [1] |
Plastic pollution [1] |
platelet count [1] |
Platelets [1] |
PLGA [1] |
PNGR [1] |
Podosome [1] |
poliomyelitis vaccine [1] |
Poliovirus Vaccines [1] |
Pollutants [1] |
polyacrylamide gel electrophoresis [1] |
Polyacrylamide Gel Electrophoresis (PAGE) [1] |
Polycystic ovary syndrome (PCOS) [1] |
Polygenic risk score [1] |
Polyherbal formulation [1] |
Polymerase Chai [1] |
Polymerase Chain Reaction [1] |
polymerase chain reaction [1] |
Polymeric prodrug [1] |
Polymorphism [1] |
Polymorphism, Single Nucleotide [1] |
PolyPhen [1] |
Polyphenol [1] |
Polyphenols [2] |
Polysaccharides [1] |
Poor outcome [1] |
population genetics [1] |
Postmenopause [1] |
Potassium Channel Kcnq1 [1] |
Potential [1] |
power conversion efficiency [1] |
Pparg Gene [1] |
PRC2 [1] |
Pre Mrna Processing Factor 31 [1] |
pre-clinical [1] |
Prebiotics [1] |
prediction [1] |
Predictor Variable [1] |
Pregnancy [1] |
Pregnancy and fetal transmission [1] |
Prenatal Diagnosis [1] |
Preschool Child [1] |
Prevalence [1] |
prevalence [1] |
Prevention [1] |
Preventive Medicine [1] |
Prime MM/GBSA [1] |
Primordial dwarfism [1] |
Priority Journal [3] |
Probiotics [3] |
Prognosis [1] |
prognosis [1] |
Prognostic Assessment [1] |
Prognostic markers [1] |
progressive keratoconus [1] |
Proline [1] |
Prooxidant [1] |
Prostaglandin G2 [1] |
Prostaglandin H2 [1] |
Prostaglandin Synthase [1] |
prostate cancer [2] |
Protease activated receptor-2 [1] |
Proteases [1] |
Protective effects [1] |
Protein [1] |
protein analysis [1] |
Protein Binding [1] |
Protein Eor 1 [1] |
Protein Expression [1] |
protein expression [2] |
Protein folding [1] |
Protein Function [1] |
protein kinase [1] |
Protein Kinase Inhibitor [1] |
Protein kinase inhibitor [1] |
Protein P21 [1] |
Protein P53 [3] |
protein p53 [1] |
Protein Protein Interaction [1] |
protein purification [1] |
protein refolding [1] |
Protein targeting [1] |
Proteinase [1] |
protein�protein interaction [1] |
Proteome [2] |
Protocol [1] |
Protozoal protein [1] |
Psoriasis [1] |
psychological
stress [1] |
Pterostilbene [1] |
PTSD [1] |
public policy [1] |
Punjabi [1] |
Pyrazoles [1] |
Pyrazolo[1,5-c]quinazolines [2] |
pyridazine [1] |
Pyrimidines [1] |
Pyrimidinone derivative [1] |
PZ [1] |
Qatar [1] |
qRT-PCR [1] |
QSAR [1] |
quality adjusted life year [1] |
quality control [1] |
Quality-Adjusted Life Years [1] |
Quercetin [4] |
Quinazoline Derivative [1] |
Quinoline [1] |
Quinolinic acid [1] |
rabbit [1] |
Rare and common variants [1] |
rat [1] |
Rats [2] |
Rats, Sprague-Dawley [1] |
RDA [1] |
Reactivation [1] |
Reactive Nitrogen Species [2] |
Reactive Oxygen Metabolite [3] |
Reactive oxygen metabolite [1] |
Reactive Oxygen Species [1] |
Reactive oxygen species [2] |
Reactive Oxygen Species (ROS) [1] |
Reactive oxygen species and cancer [1] |
Rearranged during transfection [1] |
Receptor tyrosine kinase [2] |
Recombinant Cystatin 9 [1] |
Recommended daily allowance [1] |
Recovery [1] |
Recurrence [1] |
Redox Effector Factor 1 [1] |
Regional hypermethylation [1] |
registration [1] |
release [1] |
renal protection [1] |
replication [1] |
replication licensing factor Cdt1 [1] |
Resting-state fMRI [1] |
Restriction Fragment Length Polymorphism [2] |
Resveratrol [1] |
Retinitis Pigmentosa [1] |
Review [3] |
RFLP [1] |
Rheumatoid arthritis [2] |
Rhino [1] |
Rhino-orbito-cerebral mucormycosis [1] |
rhino-orbito-cerebral mucormycosis [1] |
Rho [1] |
Rho-0 Cells [1] |
Rho/ROCK pathway [1] |
Rice bran [1] |
Ring Chromosome [1] |
Ring Chromosome 22 [1] |
risk assessment [2] |
Risk Factor [1] |
risk factor [2] |
Risk Factors [1] |
Risk factors [1] |
RNA [1] |
RNA dependent RNA polymerase [2] |
RNA isolation [1] |
RNA sequencing [1] |
RNAi [1] |
ROCK [1] |
rolipram [1] |
ROS [5] |
Ros [1] |
Rosmarinic Acid [1] |
Rosmarinic acid [1] |
Rotenone [2] |
Rs20417 Variant [1] |
Rs721917 [1] |
ryanodine receptor [1] |
Safety genetically modified organisms [1] |
Salt [1] |
SAR [1] |
SARS CoV-2 [1] |
SARS-CoV-2 [7] |
SBBI [1] |
scaffold [1] |
schizophrenia [1] |
School Child [1] |
screening [1] |
Secondary complications [1] |
Secondary metabolites [1] |
seed sequences [1] |
Seizure [1] |
Selenium nanoparticles [1] |
Selenoproteins [1] |
sepsis [2] |
sequence analysis [1] |
Sequencing [2] |
Ser7Ala Polymorphism [1] |
SERCA pump [1] |
Serine proteinase inhibitor [1] |
Serine Proteinase Omi [1] |
Sesbania grandiflora [1] |
Sesquiterpenes [1] |
Severe acute respiratory syndrome coronavirus 2 [1] |
severe acute respiratory syndrome coronavirus-2 [1] |
SFTPD [2] |
SGLT-1 [1] |
SGLT2 inhibitors [2] |
SGLT2 protein [1] |
shared mechanisms [1] |
Sickle cell [1] |
Sickle cell anaemia [1] |
Sickle cell anemia (SCD) [1] |
sickle cell disease [1] |
SIFT [1] |
Signal transduction [1] |
signal transduction [1] |
Signaling [1] |
signaling [1] |
Signaling pathways [1] |
signaling pathways [1] |
Signalling pathways [3] |
sildenafil [1] |
Silver nanoparticles [1] |
Silver-Russell Syndrome [1] |
Silver-Russell syndrome [1] |
Silymarin [1] |
simulation [1] |
Sinapic acid [1] |
Single Nucleotide Polymorphis [1] |
Single Nucleotide Polymorphism [3] |
single nucleotide polymorphism [1] |
Single nucleotide polymorphisms (SNPs) [1] |
siRNA [1] |
Sirtuin [1] |
Sirtuin 1 [2] |
sirtuin 1 [1] |
Sitgmasterol [1] |
Small Interfering Rna [1] |
small molecules [1] |
small nuclear RNA [1] |
Smar1 Protein [1] |
SNP [1] |
SNPs [2] |
social status [1] |
Socioeconomics [1] |
solar energy [1] |
Solid dispersion [1] |
South and Central America [1] |
South Asian [2] |
Spices [1] |
Spike glycoprotein [1] |
spike glycoprotein [1] |
spike protein [3] |
Spine loss [1] |
Spontaneous Abortion [1] |
spontaneous abortions [1] |
Sprague Dawley rat [1] |
Sprague-Dawley rats [1] |
spray drying [1] |
standardization [1] |
statistical analysis [1] |
Statistical parame [1] |
Steatosis [1] |
Stem Cell Therapy [1] |
Stem cell therapy [1] |
Stemness potential [1] |
Steroidal alkaloids [1] |
steroidogenesis [2] |
Stilbene [1] |
Streptozocin [1] |
Streptozotocin [2] |
Stress [2] |
Stroke [1] |
stroke [2] |
stroke treatment [1] |
structural insights [1] |
Structure [1] |
structure [2] |
Structure activity relationship (SAR) [1] |
Superoxide [1] |
Superoxide Dismutase [4] |
Superoxide dismutase [1] |
supplemental oxygen [1] |
Survival [1] |
Survival index [1] |
Susceptibility [1] |
Susceptibility genes [1] |
susceptibility genes [1] |
Synapse [2] |
Synapsin [1] |
Synapsin Ii [1] |
synergism [1] |
synergistic action [1] |
synthesis and processing techniques [1] |
Systematic review [4] |
systematic review [3] |
tadalafil [1] |
TallyHO/JngJ mice [1] |
TAM receptors [1] |
tannins [1] |
Tardive dyskinesia [2] |
tardive dyskinesia [1] |
Tardive dyskinesia (TD) [1] |
Target gene [1] |
target genes [1] |
Targeted drug delivery [2] |
Tau hyperphosphorylation [1] |
Telangana [1] |
Telophase [1] |
Temozolomide [1] |
terminalia [1] |
Tetrahydro-?-carbolines [1] |
Tetrahydro-β-carbolines [1] |
Tetrahydroimidazopyridines [2] |
Tetrahydroisoquinoline [2] |
Therapeutic interventions [1] |
Therapeutic strategies [2] |
Therapeutic targets [1] |
Therapeutic tool [1] |
Therapeutics [5] |
therapeutics [1] |
Therapy [1] |
therapy [1] |
Thioredoxin [2] |
Thrombocyte Aggregation [1] |
Thymine [2] |
Thyroid [1] |
Thyroid disorders [1] |
Thyroid gland [1] |
time factor [1] |
Time Factors [1] |
tissue engineering [1] |
tissue microarray [1] |
TMPRSS2 [1] |
TNF-? [1] |
tobacco use [1] |
Toll Like Receptor 4 [1] |
Topoisomerase [1] |
Topoisomerase inhibition [1] |
Topoisomerase inhibitors [2] |
Total phenol [1] |
toxicity [1] |
Trace elements [1] |
Trans cinnamaldehyde [1] |
Transcription [2] |
Transcription Factor [2] |
transcription factor [1] |
Transcription Factor Daf 16 [1] |
Transcription Factor Fkhrl1 Caenorhabditis Elegans [1] |
Transcription Factor Foxo [1] |
Transcription Factor Nrf1 [1] |
Transcription Factor Pax8 [1] |
Transcription Factors [1] |
Transdermal [1] |
Transfection [1] |
transfection [1] |
Transfer RNA fragments [1] |
Transferrin [1] |
Transgenic [1] |
transmembrane protease serine 2 [1] |
Transmembrane serine protease 2 [1] |
Transpeptidase [1] |
transwell assay [1] |
Trastuzumab [2] |
trastuzumab resistance [1] |
Trastuzumab. [1] |
trauma [1] |
traumatic brain injury [1] |
Treatment [1] |
treatment [1] |
trend study [1] |
Triacylglycerol [2] |
Triazole [1] |
Triglyceride [1] |
Triple-negative breast cancer [1] |
Tropomyosin kinase receptors [1] |
Trypanosoma [1] |
Tryparedoxin [1] |
Tryparedoxin peroxidase [1] |
Tryptophan [1] |
Tryptophan metabolism [1] |
Tuberculosis [1] |
Tumor angiogenesis [1] |
Tumor growth [1] |
tumor invasion [1] |
Tumor Promoter [1] |
tumor suppressor [1] |
tumor suppressor p53 [1] |
Tumor Suppressor Protein [1] |
tumor suppressor protein [1] |
Tumor Suppressor Protein p53 [1] |
tumor xenograft [1] |
Tumorigenesis [1] |
Turbidometric analysis [1] |
Type 1 diabetes mellitus [1] |
Type 2 diabetes [4] |
type 2 diabetes [1] |
type 2 diabetes mellitus [1] |
Type-2 diabetes [1] |
type-2 diabetes [1] |
Tyro 3 [1] |
Ugt1A6 Gene [1] |
ulcerative colitis [1] |
Uncl [1] |
Unclassified Drug [7] |
Unclassified drug [3] |
unclassified drug [1] |
Unclassified Drug Biodegradation [1] |
Unfolded Protein Response [1] |
Unfolded protein response [1] |
uniparental disomy [1] |
Untranslated Rna [1] |
UPR [1] |
Upregulation [1] |
Uracil [1] |
utlity [1] |
UTX [1] |
Vaccination Coverage [1] |
vaccination coverage [1] |
Vaccine [1] |
Vaccines [2] |
validation [1] |
Valproic Acid [2] |
vardenafil [1] |
Variants [1] |
Vascular function [2] |
Vascular leakage [1] |
Vascular smooth muscle cells [1] |
Vegetarian [1] |
VEGF [1] |
Verucerfont [1] |
Very Low Density Lipoprotein [1] |
Very Low Density Lipoprotein Cholesterol [1] |
Vincamine [1] |
Viral vectors [1] |
Visual Acuity; [1] |
Vitamin [1] |
vitamin blood level [1] |
Vitamin D [1] |
vitamin D [1] |
Vitamin D Deficiency [1] |
vitamin D deficiency [3] |
vitamin D receptor [1] |
Vitamin D-binding protein [1] |
vitiligo [1] |
VOCs [1] |
Vulvovaginal candidiasis [1] |
wedelia [1] |
Wegener�s granulomatosis [1] |
weight drop model [1] |
Western blotting [1] |
WHO [2] |
Whole Exome Sequencing [1] |
Withania [1] |
Withania somnifera [2] |
Withania somnifera extract [1] |
Wonder material [1] |
zaprinast [1] |
Zebrafish [3] |
Zingiber roseum [2] |
Zingiberaceae [1] |
β -thalassemia [1] |